Literature DB >> 1736281

Transactivation of the proenkephalin gene promoter by the Tax1 protein of human T-cell lymphotropic virus type I.

J B Joshi1, H P Dave.   

Abstract

Human T-cell lymphotropic virus type I (HTLV-I), an etiologic agent for adult T-cell leukemia, is strongly associated with certain neurological diseases. The HTLV-I genome encodes a protein, Tax1, that transactivates viral gene transcription. CD4-positive T helper lymphocytes express the proenkephalin gene, and enkephalins have been implicated as neuroimmunomodulators. We have investigated the effect of Tax1 on the proenkephalin gene promoter in C6 rat glioma cells and demonstrated its transactivation. Analysis using 5' deletion mutants of the promoter region showed that sequences upstream of base pair -190 are necessary for maximal transactivation. Forskolin, a cAMP modulator, synergistically increased Tax1-mediated transactivation of the proenkephalin promoter. Neither Tax1 transactivation alone nor Tax1/cAMP synergism exclusively involved cAMP-responsive elements. Endogenous proenkephalin gene expression increased in Tax1-expressing C6 cells. Since HTLV-I infects lymphocytes, which express proenkephalin mRNA, Tax1 transregulation of proenkephalin expression may provide bidirectional communication between the nervous and immune systems in HTLV-I-related diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736281      PMCID: PMC48374          DOI: 10.1073/pnas.89.3.1006

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Indirect binding of human T-cell leukemia virus type I tax1 to a responsive element in the viral long terminal repeat.

Authors:  S J Marriott; I Boros; J F Duvall; J N Brady
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

2.  The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats.

Authors:  B K Felber; H Paskalis; C Kleinman-Ewing; F Wong-Staal; G N Pavlakis
Journal:  Science       Date:  1985-08-16       Impact factor: 47.728

3.  Identification of regulatory elements of cloned genes with functional assays.

Authors:  N Rosenthal
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

5.  Trans-activation of human globin genes by HTLV-I tax1.

Authors:  H B Fox; P D Gutman; H P Dave; S X Cao; M Mittelman; P E Berg; A N Schechter
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

6.  Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.

Authors:  M Siekevitz; M B Feinberg; N Holbrook; F Wong-Staal; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription.

Authors:  K Shimotohno; M Takano; T Teruuchi; M Miwa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

8.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

9.  Proenkephalin gene expression in C6 rat glioma cells: potentiation of cyclic adenosine 3',5'-monophosphate-dependent transcription by glucocorticoids.

Authors:  J Joshi; S L Sabol
Journal:  Mol Endocrinol       Date:  1991-08

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  6 in total

1.  Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a.

Authors:  K G Low; L F Dorner; D B Fernando; J Grossman; K T Jeang; M J Comb
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 2.  The transcriptional regulation of the preproenkephalin gene.

Authors:  G Weisinger
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

3.  Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3.

Authors:  E Muñoz; G Courtois; P Veschambre; P Jalinot; A Israël
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Cellular pathways involved in the ex vivo expression of bovine leukemia virus.

Authors:  P Kerkhofs; E Adam; L Droogmans; D Portetelle; M Mammerickx; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Human T-cell leukemia virus type 1 oncoprotein tax represses ZNF268 expression through the cAMP-responsive element-binding protein/activating transcription factor pathway.

Authors:  Di Wang; Ming-Xiong Guo; Hai-Ming Hu; Zhou-Zhou Zhao; Hong-Ling Qiu; Huan-Jie Shao; Chen-Gang Zhu; Lu Xue; Yun-Bo Shi; Wen-Xin Li
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

6.  Novel interactions between human T-cell leukemia virus type I Tax and activating transcription factor 3 at a cyclic AMP-responsive element.

Authors:  K G Low; H M Chu; P M Schwartz; G M Daniels; M H Melner; M J Comb
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.